Not admitted · Commitment (own venture)
Rules 1.1.0 · as of 14 Sep 2026
Rick Doblin · Said Jun 2023 · doblin-0191
Quote
Commitment (own venture)
“we think around September of this year, we're going to be submitting what's called the NDAA, the new drug application to the FDA. And we think there's a very good chance that by June of 2020, for roughly one year from now, we think that FDA may indeed go ahead and approve MDMA assisted therapy as a prescription treatment for PTSD.”
Reason interview with Nick Gillespie at Psychedelic Science 2023. Doblin gives the NDA submission timing (September 2023) and the expected FDA approval window (June 2024, 'roughly one year from now'). Transcript reads 'June of 2020' (transcription artifact for 2024).
The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.